CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to detect and destroy DNA from similar bacteriophages during subsequent infections. Hence these sequences play a key role in the antiviral (i.e. anti-phage) defense system of prokaryotes.

Cas9 (or "CRISPR-associated protein 9") is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms. This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.

Diagram of the CRISPR prokaryotic antiviral defense mechanism. The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages and provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA.

Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.

The global CRISPR & Cas Genes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for CRISPR & Cas Genes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for CRISPR & Cas Genes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for CRISPR & Cas Genes in Biotechnology and Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of CRISPR & Cas Genes include CRISPR Therapeutics, AstraZeneca, Addgene, Caribou Biosciences, Inc., Cellectis, Editas Medicine, Inc., Egenesis, F. Hoffmann-La Roche Ltd. and Horizon Discovery Group Plc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for CRISPR & Cas Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR & Cas Genes.

Report Scope

The CRISPR & Cas Genes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR & Cas Genes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CRISPR & Cas Genes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CRISPR & Cas Genes Market Report

Report Metric	Details
Report Name	CRISPR & Cas Genes Market
Segment by Type	Vector-based Cas DNA-free Cas Cell Line Engineering
Segment by Application	Biotechnology and Pharmaceutical Companies Academics and Government Research Institutes Contract Research Organizations (CROs)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CRISPR Therapeutics, AstraZeneca, Addgene, Caribou Biosciences, Inc., Cellectis, Editas Medicine, Inc., Egenesis, F. Hoffmann-La Roche Ltd., Horizon Discovery Group Plc, Genscrip, Danaher Corporation, Intellia Therapeutics, Inc., Lonza, Merck KGaA, New England BioLabs, Takara Bio, Inc., Synthego, Mammoth Biosciences, Inscripta, Inc., Cibus
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR & Cas Genes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CRISPR & Cas Genes Market report?

Ans: The main players in the CRISPR & Cas Genes Market are CRISPR Therapeutics, AstraZeneca, Addgene, Caribou Biosciences, Inc., Cellectis, Editas Medicine, Inc., Egenesis, F. Hoffmann-La Roche Ltd., Horizon Discovery Group Plc, Genscrip, Danaher Corporation, Intellia Therapeutics, Inc., Lonza, Merck KGaA, New England BioLabs, Takara Bio, Inc., Synthego, Mammoth Biosciences, Inscripta, Inc., Cibus

What are the Application segmentation covered in the CRISPR & Cas Genes Market report?

Ans: The Applications covered in the CRISPR & Cas Genes Market report are Biotechnology and Pharmaceutical Companies, Academics and Government Research Institutes, Contract Research Organizations (CROs)

What are the Type segmentation covered in the CRISPR & Cas Genes Market report?

Ans: The Types covered in the CRISPR & Cas Genes Market report are Vector-based Cas, DNA-free Cas, Cell Line Engineering

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CRISPR & Cas Genes Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Vector-based Cas

1.2.3 DNA-free Cas

1.2.4 Cell Line Engineering

1.3 Market by Application

1.3.1 Global CRISPR & Cas Genes Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Biotechnology and Pharmaceutical Companies

1.3.3 Academics and Government Research Institutes

1.3.4 Contract Research Organizations (CROs)

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global CRISPR & Cas Genes Market Perspective (2019-2030)

2.2 CRISPR & Cas Genes Growth Trends by Region

2.2.1 Global CRISPR & Cas Genes Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 CRISPR & Cas Genes Historic Market Size by Region (2019-2024)

2.2.3 CRISPR & Cas Genes Forecasted Market Size by Region (2025-2030)

2.3 CRISPR & Cas Genes Market Dynamics

2.3.1 CRISPR & Cas Genes Industry Trends

2.3.2 CRISPR & Cas Genes Market Drivers

2.3.3 CRISPR & Cas Genes Market Challenges

2.3.4 CRISPR & Cas Genes Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CRISPR & Cas Genes Players by Revenue

3.1.1 Global Top CRISPR & Cas Genes Players by Revenue (2019-2024)

3.1.2 Global CRISPR & Cas Genes Revenue Market Share by Players (2019-2024)

3.2 Global CRISPR & Cas Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by CRISPR & Cas Genes Revenue

3.4 Global CRISPR & Cas Genes Market Concentration Ratio

3.4.1 Global CRISPR & Cas Genes Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas Genes Revenue in 2023

3.5 CRISPR & Cas Genes Key Players Head office and Area Served

3.6 Key Players CRISPR & Cas Genes Product Solution and Service

3.7 Date of Enter into CRISPR & Cas Genes Market

3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR & Cas Genes Breakdown Data by Type

4.1 Global CRISPR & Cas Genes Historic Market Size by Type (2019-2024)

4.2 Global CRISPR & Cas Genes Forecasted Market Size by Type (2025-2030)

5 CRISPR & Cas Genes Breakdown Data by Application

5.1 Global CRISPR & Cas Genes Historic Market Size by Application (2019-2024)

5.2 Global CRISPR & Cas Genes Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America CRISPR & Cas Genes Market Size (2019-2030)

6.2 North America CRISPR & Cas Genes Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America CRISPR & Cas Genes Market Size by Country (2019-2024)

6.4 North America CRISPR & Cas Genes Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CRISPR & Cas Genes Market Size (2019-2030)

7.2 Europe CRISPR & Cas Genes Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe CRISPR & Cas Genes Market Size by Country (2019-2024)

7.4 Europe CRISPR & Cas Genes Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CRISPR & Cas Genes Market Size (2019-2030)

8.2 Asia-Pacific CRISPR & Cas Genes Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific CRISPR & Cas Genes Market Size by Region (2019-2024)

8.4 Asia-Pacific CRISPR & Cas Genes Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CRISPR & Cas Genes Market Size (2019-2030)

9.2 Latin America CRISPR & Cas Genes Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America CRISPR & Cas Genes Market Size by Country (2019-2024)

9.4 Latin America CRISPR & Cas Genes Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CRISPR & Cas Genes Market Size (2019-2030)

10.2 Middle East & Africa CRISPR & Cas Genes Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa CRISPR & Cas Genes Market Size by Country (2019-2024)

10.4 Middle East & Africa CRISPR & Cas Genes Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 CRISPR Therapeutics

11.1.1 CRISPR Therapeutics Company Detail

11.1.2 CRISPR Therapeutics Business Overview

11.1.3 CRISPR Therapeutics CRISPR & Cas Genes Introduction

11.1.4 CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2019-2024)

11.1.5 CRISPR Therapeutics Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Detail

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca CRISPR & Cas Genes Introduction

11.2.4 AstraZeneca Revenue in CRISPR & Cas Genes Business (2019-2024)

11.2.5 AstraZeneca Recent Development

11.3 Addgene

11.3.1 Addgene Company Detail

11.3.2 Addgene Business Overview

11.3.3 Addgene CRISPR & Cas Genes Introduction

11.3.4 Addgene Revenue in CRISPR & Cas Genes Business (2019-2024)

11.3.5 Addgene Recent Development

11.4 Caribou Biosciences, Inc.

11.4.1 Caribou Biosciences, Inc. Company Detail

11.4.2 Caribou Biosciences, Inc. Business Overview

11.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Introduction

11.4.4 Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024)

11.4.5 Caribou Biosciences, Inc. Recent Development

11.5 Cellectis

11.5.1 Cellectis Company Detail

11.5.2 Cellectis Business Overview

11.5.3 Cellectis CRISPR & Cas Genes Introduction

11.5.4 Cellectis Revenue in CRISPR & Cas Genes Business (2019-2024)

11.5.5 Cellectis Recent Development

11.6 Editas Medicine, Inc.

11.6.1 Editas Medicine, Inc. Company Detail

11.6.2 Editas Medicine, Inc. Business Overview

11.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Introduction

11.6.4 Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024)

11.6.5 Editas Medicine, Inc. Recent Development

11.7 Egenesis

11.7.1 Egenesis Company Detail

11.7.2 Egenesis Business Overview

11.7.3 Egenesis CRISPR & Cas Genes Introduction

11.7.4 Egenesis Revenue in CRISPR & Cas Genes Business (2019-2024)

11.7.5 Egenesis Recent Development

11.8 F. Hoffmann-La Roche Ltd.

11.8.1 F. Hoffmann-La Roche Ltd. Company Detail

11.8.2 F. Hoffmann-La Roche Ltd. Business Overview

11.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Introduction

11.8.4 F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2019-2024)

11.8.5 F. Hoffmann-La Roche Ltd. Recent Development

11.9 Horizon Discovery Group Plc

11.9.1 Horizon Discovery Group Plc Company Detail

11.9.2 Horizon Discovery Group Plc Business Overview

11.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Introduction

11.9.4 Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2019-2024)

11.9.5 Horizon Discovery Group Plc Recent Development

11.10 Genscrip

11.10.1 Genscrip Company Detail

11.10.2 Genscrip Business Overview

11.10.3 Genscrip CRISPR & Cas Genes Introduction

11.10.4 Genscrip Revenue in CRISPR & Cas Genes Business (2019-2024)

11.10.5 Genscrip Recent Development

11.11 Danaher Corporation

11.11.1 Danaher Corporation Company Detail

11.11.2 Danaher Corporation Business Overview

11.11.3 Danaher Corporation CRISPR & Cas Genes Introduction

11.11.4 Danaher Corporation Revenue in CRISPR & Cas Genes Business (2019-2024)

11.11.5 Danaher Corporation Recent Development

11.12 Intellia Therapeutics, Inc.

11.12.1 Intellia Therapeutics, Inc. Company Detail

11.12.2 Intellia Therapeutics, Inc. Business Overview

11.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Introduction

11.12.4 Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024)

11.12.5 Intellia Therapeutics, Inc. Recent Development

11.13 Lonza

11.13.1 Lonza Company Detail

11.13.2 Lonza Business Overview

11.13.3 Lonza CRISPR & Cas Genes Introduction

11.13.4 Lonza Revenue in CRISPR & Cas Genes Business (2019-2024)

11.13.5 Lonza Recent Development

11.14 Merck KGaA

11.14.1 Merck KGaA Company Detail

11.14.2 Merck KGaA Business Overview

11.14.3 Merck KGaA CRISPR & Cas Genes Introduction

11.14.4 Merck KGaA Revenue in CRISPR & Cas Genes Business (2019-2024)

11.14.5 Merck KGaA Recent Development

11.15 New England BioLabs

11.15.1 New England BioLabs Company Detail

11.15.2 New England BioLabs Business Overview

11.15.3 New England BioLabs CRISPR & Cas Genes Introduction

11.15.4 New England BioLabs Revenue in CRISPR & Cas Genes Business (2019-2024)

11.15.5 New England BioLabs Recent Development

11.16 Takara Bio, Inc.

11.16.1 Takara Bio, Inc. Company Detail

11.16.2 Takara Bio, Inc. Business Overview

11.16.3 Takara Bio, Inc. CRISPR & Cas Genes Introduction

11.16.4 Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024)

11.16.5 Takara Bio, Inc. Recent Development

11.17 Synthego

11.17.1 Synthego Company Detail

11.17.2 Synthego Business Overview

11.17.3 Synthego CRISPR & Cas Genes Introduction

11.17.4 Synthego Revenue in CRISPR & Cas Genes Business (2019-2024)

11.17.5 Synthego Recent Development

11.18 Mammoth Biosciences

11.18.1 Mammoth Biosciences Company Detail

11.18.2 Mammoth Biosciences Business Overview

11.18.3 Mammoth Biosciences CRISPR & Cas Genes Introduction

11.18.4 Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2019-2024)

11.18.5 Mammoth Biosciences Recent Development

11.19 Inscripta, Inc.

11.19.1 Inscripta, Inc. Company Detail

11.19.2 Inscripta, Inc. Business Overview

11.19.3 Inscripta, Inc. CRISPR & Cas Genes Introduction

11.19.4 Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024)

11.19.5 Inscripta, Inc. Recent Development

11.20 Cibus

11.20.1 Cibus Company Detail

11.20.2 Cibus Business Overview

11.20.3 Cibus CRISPR & Cas Genes Introduction

11.20.4 Cibus Revenue in CRISPR & Cas Genes Business (2019-2024)

11.20.5 Cibus Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

CRISPR Therapeutics

Astrazeneca plc

Addgene

Caribou Biosciences, Inc.

CELLECTIS

Editas Medicine Inc

Egenesis

F Hoffmann La Roche Ltd

Horizon Discovery Group plc

GenScrip

Danaher Corporation

Intellia Therapeutics Inc

List of Tables

Table 1. Global CRISPR & Cas Genes Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Vector-based Cas

Table 3. Key Players of DNA-free Cas

Table 4. Key Players of Cell Line Engineering

Table 5. Global CRISPR & Cas Genes Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global CRISPR & Cas Genes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global CRISPR & Cas Genes Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global CRISPR & Cas Genes Market Share by Region (2019-2024)

Table 9. Global CRISPR & Cas Genes Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global CRISPR & Cas Genes Market Share by Region (2025-2030)

Table 11. CRISPR & Cas Genes Market Trends

Table 12. CRISPR & Cas Genes Market Drivers

Table 13. CRISPR & Cas Genes Market Challenges

Table 14. CRISPR & Cas Genes Market Restraints

Table 15. Global CRISPR & Cas Genes Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global CRISPR & Cas Genes Market Share by Players (2019-2024)

Table 17. Global Top CRISPR & Cas Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas Genes as of 2023)

Table 18. Ranking of Global Top CRISPR & Cas Genes Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by CRISPR & Cas Genes Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players CRISPR & Cas Genes Product Solution and Service

Table 22. Date of Enter into CRISPR & Cas Genes Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global CRISPR & Cas Genes Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global CRISPR & Cas Genes Revenue Market Share by Type (2019-2024)

Table 26. Global CRISPR & Cas Genes Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global CRISPR & Cas Genes Revenue Market Share by Type (2025-2030)

Table 28. Global CRISPR & Cas Genes Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global CRISPR & Cas Genes Revenue Market Share by Application (2019-2024)

Table 30. Global CRISPR & Cas Genes Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global CRISPR & Cas Genes Revenue Market Share by Application (2025-2030)

Table 32. North America CRISPR & Cas Genes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America CRISPR & Cas Genes Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America CRISPR & Cas Genes Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe CRISPR & Cas Genes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe CRISPR & Cas Genes Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe CRISPR & Cas Genes Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific CRISPR & Cas Genes Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific CRISPR & Cas Genes Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific CRISPR & Cas Genes Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America CRISPR & Cas Genes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America CRISPR & Cas Genes Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America CRISPR & Cas Genes Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa CRISPR & Cas Genes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa CRISPR & Cas Genes Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa CRISPR & Cas Genes Market Size by Country (2025-2030) & (US$ Million)

Table 47. CRISPR Therapeutics Company Detail

Table 48. CRISPR Therapeutics Business Overview

Table 49. CRISPR Therapeutics CRISPR & Cas Genes Product

Table 50. CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 51. CRISPR Therapeutics Recent Development

Table 52. AstraZeneca Company Detail

Table 53. AstraZeneca Business Overview

Table 54. AstraZeneca CRISPR & Cas Genes Product

Table 55. AstraZeneca Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 56. AstraZeneca Recent Development

Table 57. Addgene Company Detail

Table 58. Addgene Business Overview

Table 59. Addgene CRISPR & Cas Genes Product

Table 60. Addgene Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 61. Addgene Recent Development

Table 62. Caribou Biosciences, Inc. Company Detail

Table 63. Caribou Biosciences, Inc. Business Overview

Table 64. Caribou Biosciences, Inc. CRISPR & Cas Genes Product

Table 65. Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 66. Caribou Biosciences, Inc. Recent Development

Table 67. Cellectis Company Detail

Table 68. Cellectis Business Overview

Table 69. Cellectis CRISPR & Cas Genes Product

Table 70. Cellectis Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 71. Cellectis Recent Development

Table 72. Editas Medicine, Inc. Company Detail

Table 73. Editas Medicine, Inc. Business Overview

Table 74. Editas Medicine, Inc. CRISPR & Cas Genes Product

Table 75. Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 76. Editas Medicine, Inc. Recent Development

Table 77. Egenesis Company Detail

Table 78. Egenesis Business Overview

Table 79. Egenesis CRISPR & Cas Genes Product

Table 80. Egenesis Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 81. Egenesis Recent Development

Table 82. F. Hoffmann-La Roche Ltd. Company Detail

Table 83. F. Hoffmann-La Roche Ltd. Business Overview

Table 84. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Product

Table 85. F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 86. F. Hoffmann-La Roche Ltd. Recent Development

Table 87. Horizon Discovery Group Plc Company Detail

Table 88. Horizon Discovery Group Plc Business Overview

Table 89. Horizon Discovery Group Plc CRISPR & Cas Genes Product

Table 90. Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 91. Horizon Discovery Group Plc Recent Development

Table 92. Genscrip Company Detail

Table 93. Genscrip Business Overview

Table 94. Genscrip CRISPR & Cas Genes Product

Table 95. Genscrip Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 96. Genscrip Recent Development

Table 97. Danaher Corporation Company Detail

Table 98. Danaher Corporation Business Overview

Table 99. Danaher Corporation CRISPR & Cas Genes Product

Table 100. Danaher Corporation Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 101. Danaher Corporation Recent Development

Table 102. Intellia Therapeutics, Inc. Company Detail

Table 103. Intellia Therapeutics, Inc. Business Overview

Table 104. Intellia Therapeutics, Inc. CRISPR & Cas Genes Product

Table 105. Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 106. Intellia Therapeutics, Inc. Recent Development

Table 107. Lonza Company Detail

Table 108. Lonza Business Overview

Table 109. Lonza CRISPR & Cas Genes Product

Table 110. Lonza Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 111. Lonza Recent Development

Table 112. Merck KGaA Company Detail

Table 113. Merck KGaA Business Overview

Table 114. Merck KGaA CRISPR & Cas Genes Product

Table 115. Merck KGaA Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 116. Merck KGaA Recent Development

Table 117. New England BioLabs Company Detail

Table 118. New England BioLabs Business Overview

Table 119. New England BioLabs CRISPR & Cas Genes Product

Table 120. New England BioLabs Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 121. New England BioLabs Recent Development

Table 122. Takara Bio, Inc. Company Detail

Table 123. Takara Bio, Inc. Business Overview

Table 124. Takara Bio, Inc. CRISPR & Cas Genes Product

Table 125. Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 126. Takara Bio, Inc. Recent Development

Table 127. Synthego Company Detail

Table 128. Synthego Business Overview

Table 129. Synthego CRISPR & Cas Genes Product

Table 130. Synthego Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 131. Synthego Recent Development

Table 132. Mammoth Biosciences Company Detail

Table 133. Mammoth Biosciences Business Overview

Table 134. Mammoth Biosciences CRISPR & Cas Genes Product

Table 135. Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 136. Mammoth Biosciences Recent Development

Table 137. Inscripta, Inc. Company Detail

Table 138. Inscripta, Inc. Business Overview

Table 139. Inscripta, Inc. CRISPR & Cas Genes Product

Table 140. Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 141. Inscripta, Inc. Recent Development

Table 142. Cibus Company Detail

Table 143. Cibus Business Overview

Table 144. Cibus CRISPR & Cas Genes Product

Table 145. Cibus Revenue in CRISPR & Cas Genes Business (2019-2024) & (US$ Million)

Table 146. Cibus Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Global CRISPR & Cas Genes Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global CRISPR & Cas Genes Market Share by Type: 2023 VS 2030

Figure 3. Vector-based Cas Features

Figure 4. DNA-free Cas Features

Figure 5. Cell Line Engineering Features

Figure 6. Global CRISPR & Cas Genes Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global CRISPR & Cas Genes Market Share by Application: 2023 VS 2030

Figure 8. Biotechnology and Pharmaceutical Companies Case Studies

Figure 9. Academics and Government Research Institutes Case Studies

Figure 10. Contract Research Organizations (CROs) Case Studies

Figure 11. CRISPR & Cas Genes Report Years Considered

Figure 12. Global CRISPR & Cas Genes Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global CRISPR & Cas Genes Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global CRISPR & Cas Genes Market Share by Region: 2023 VS 2030

Figure 15. Global CRISPR & Cas Genes Market Share by Players in 2023

Figure 16. Global Top CRISPR & Cas Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas Genes as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by CRISPR & Cas Genes Revenue in 2023

Figure 18. North America CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America CRISPR & Cas Genes Market Share by Country (2019-2030)

Figure 20. United States CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe CRISPR & Cas Genes Market Share by Country (2019-2030)

Figure 24. Germany CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific CRISPR & Cas Genes Market Share by Region (2019-2030)

Figure 32. China CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America CRISPR & Cas Genes Market Share by Country (2019-2030)

Figure 40. Mexico CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa CRISPR & Cas Genes Market Share by Country (2019-2030)

Figure 44. Turkey CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia CRISPR & Cas Genes Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. CRISPR Therapeutics Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 47. AstraZeneca Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 48. Addgene Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 49. Caribou Biosciences, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 50. Cellectis Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 51. Editas Medicine, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 52. Egenesis Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 53. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 54. Horizon Discovery Group Plc Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 55. Genscrip Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 56. Danaher Corporation Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 57. Intellia Therapeutics, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 58. Lonza Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 59. Merck KGaA Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 60. New England BioLabs Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 61. Takara Bio, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 62. Synthego Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 63. Mammoth Biosciences Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 64. Inscripta, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 65. Cibus Revenue Growth Rate in CRISPR & Cas Genes Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-33U12842

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Optical Genome Mapping Technology Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2Z13196

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Neuronal Cell Medium Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35A10377

Tue May 14 00:00:00 UTC 2024

Add to Cart

Global Plasmid DNA Preparation Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-16U11917

Tue May 14 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global CRISPR & Cas Genes Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-24S5533

Global CRISPR & Cas Genes Market Research Report 2024

FEATURED COMPANIES

CRISPR & Cas Genes Market

Report Scope

Scope of CRISPR & Cas Genes Market Report

Chapter Outline

FAQ for this report

Who are the main players in the CRISPR & Cas Genes Market report?

What are the Application segmentation covered in the CRISPR & Cas Genes Market report?

What are the Type segmentation covered in the CRISPR & Cas Genes Market report?

FEATURED COMPANIES

RELATED REPORTS